Clin2
NCT07612566Likely a fitNot yet recruiting

Blood immune markers for pancreatitis and pancreatic cancer risk

Chronic PancreatitisPancreatic Cancer

Part of Cancer, Digestive system, Hormones & metabolism clinical trials.

This study analyzes immune system markers in blood samples to help predict which people with chronic pancreatitis (long-term pancreas inflammation) might develop pancreatic cancer. Researchers will compare blood patterns in healthy people, those with chronic pancreatitis, and those recently diagnosed with pancreatic cancer.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
800 people
Ages
18 years and older
Study type
Observational

Who can take part

  • Be 18 years or older
  • Able to understand the study and sign consent forms
  • Willing to give blood samples and share medical information
  • If you have chronic pancreatitis: willing to return for follow-up visits every 6 to 12 months
  • No active cancer other than non-melanoma skin cancer treated in the past
  • Not currently on immune-suppressing medications or recent cancer immunotherapy

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07762950Not yet recruiting
Blood and gut bacteria tests for pancreatic cancer risk

This study looks at how certain substances in your blood and bacteria in your gut might help predict pancreatic cancer, especially in people with chronic pancreatitis. It aims to find early warning signs to catch cancer sooner.

NCT03311776Recruiting
Study blood and tissue markers in pancreatic cancer

This study looks at “biomarkers” (test signals in tissue or blood) in people with pancreatic cancer. It may help researchers understand the disease better and find ways to predict or track it.

Herlev
NCT03334708Recruiting
Blood test study for pancreatic cancer

This study looks at blood tests to find markers that may help detect and monitor pancreatic cancer. It compares people with pancreatic cancer to those with benign pancreatic conditions and healthy volunteers.

Middletown, New Jersey
NCT06166147Recruiting
Blood test for early detection of pancreatic cancer

This study is testing a new blood test to find pancreatic cancer early. It looks for tiny bits of cancer DNA floating in your blood, which could help catch the disease before symptoms start.

Shanghai, Shanghai Municipality
NCT03568630Recruiting
Blood tests to study early pancreatic cancer risk

This study looks at blood “markers” to find early signs or higher risk for pancreatic cancer. You may join if you have certain risk factors (like new diabetes, pancreatic cysts/pancreatitis, or a strong family history) and can come to Omaha for blood draws twice a year.

Omaha, Nebraska
NCT06826729Not yet recruiting
Blood sugar and hormone changes in chronic pancreatitis with diabetes

This study looks at how blood sugar and certain hormones change in people who have both chronic pancreatitis and diabetes. It aims to understand these patterns better, which might help design future treatments.

Hear when a new Chronic Pancreatitis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.